Drugs

Selenium-Based Antihypertensives: Rationale and Potential
pp. 959-964(6)
Authors: May S.W.; Pollock S.H.

Recent Antiplatelet Drug Trials in the Acute Coronary Syndromes: Clinical Interpretation of PRISM, PRISM-PLUS, PARAGON A and PURSUIT
pp. 965-976(12)
Authors: Alexander J.H.; Harrington R.A.

Adhesion Molecules in Inflammatory Diseases
pp. 977-988(12)
Authors: González-Amaro R.; Díaz-González F.; Sánchez-Madrid F.

Recognition and Management of Pulmonary Hypertension
pp. 989-1007(19)
Authors: Wanstall J.C.; Jeffery T.K.

Practical Guide for the Treatment of Leishmaniasis
pp. 1009-1018(10)
Author: Davidson R.N.

Practical Treatment Guide for Dose Individualisation in Cancer Chemotherapy
pp. 1019-1038(20)
Authors: Canal P.; Chatelut E.; Guichard S.

Telmisartan
pp. 1039-1044(6)
Authors: McClellan K.J.; Markham A.

Telmisartan: A Viewpoint by H.L. Elliott
pp. 1045-1046(2)
Author: Elliott H.L.

Telmisartan: A Viewpoint by Wilbert S. Aronow
pp. 1045-1046(2)
Author: Aronow W.S.

Telmisartan: A Viewpoint by Norman Sharpe
pp. 1045-1046(2)
Author: Sharpe N.

Pexiganan Acetate
pp. 1047-1052(6)
Authors: Lamb H.M.; Wiseman L.R.

Pexiganan Acetate: A Viewpoint by Benjamin A. Lipsky
pp. 1053-1054(2)
Author: Lipsky B.A.

Pexiganan Acetate: A Viewpoint by Richard Wise
pp. 1053-1054(2)
Author: Wise R.

Efavirenz
pp. 1055-1064(10)
Authors: Adkins J.C.; Noble S.

Efavirenz: A Viewpoint by Philippa J. Easterbrook
pp. 1065-1066(2)
Author: Easterbrook P.J.

Efavirenz: A Viewpoint by Brian Conway
pp. 1065-1066(2)
Author: Conway B.

Tirofiban: A Review of its Use in Acute Coronary Syndromes
pp. 1067-1080(14)
Authors: McClellan K.J.; Goa K.L.

Theophylline: A Review of its Potential Steroid Sparing Effects in Asthma
pp. 1081-1091(11)
Authors: Markham A.; Faulds D.

Sibutramine: A Review of its Contribution to the Management of Obesity
pp. 1093-1124(32)
Authors: McNeely W.; Goa K.L.

Letrozole: A Review of its Use in Postmenopausal Women with Advanced Breast Cancer
pp. 1125-1140(16)
Authors: Lamb H.M.; Adkins J.C.